These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17130198)

  • 1. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor.
    Garg S; Jovanovic L
    Diabetes Care; 2006 Dec; 29(12):2644-9. PubMed ID: 17130198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
    Garg S; Zisser H; Schwartz S; Bailey T; Kaplan R; Ellis S; Jovanovic L
    Diabetes Care; 2006 Jan; 29(1):44-50. PubMed ID: 16373894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of congestive heart failure on sensor accuracy among hospitalized patients with type 2 diabetes.
    Dungan K; Graessle K; Sagrilla C
    Diabetes Technol Ther; 2013 Oct; 15(10):817-24. PubMed ID: 24050738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
    Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
    Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.
    Thabit H; Leelarathna L; Wilinska ME; Elleri D; Allen JM; Lubina-Solomon A; Walkinshaw E; Stadler M; Choudhary P; Mader JK; Dellweg S; Benesch C; Pieber TR; Arnolds S; Heller SR; Amiel SA; Dunger D; Evans ML; Hovorka R
    Diabetes Technol Ther; 2015 Nov; 17(11):801-7. PubMed ID: 26241693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
    Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
    Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes.
    Maahs DM; Chase HP; Westfall E; Slover R; Huang S; Shin JJ; Kaufman FR; Pyle L; Snell-Bergeon JK
    Diabetes Technol Ther; 2014 May; 16(5):284-91. PubMed ID: 24450776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time.
    Bailey T; Zisser H; Chang A
    Diabetes Technol Ther; 2009 Dec; 11(12):749-55. PubMed ID: 20001675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study.
    Garg SK; Voelmle MK; Beatson CR; Miller HA; Crew LB; Freson BJ; Hazenfield RM
    Diabetes Care; 2011 Mar; 34(3):574-9. PubMed ID: 21278138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study.
    Zhou J; Lv X; Mu Y; Wang X; Li J; Zhang X; Wu J; Bao Y; Jia W
    Diabetes Technol Ther; 2012 Aug; 14(8):710-8. PubMed ID: 22853722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes.
    Mastrototaro J; Shin J; Marcus A; Sulur G;
    Diabetes Technol Ther; 2008 Oct; 10(5):385-90. PubMed ID: 18715215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study.
    Logtenberg SJ; Kleefstra N; Groenier KH; Gans RO; Bilo HJ
    Diabetes Technol Ther; 2009 May; 11(5):293-9. PubMed ID: 19425877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.
    Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Farish S; Hamblin PS; O'Connell MA; Rodda C; Rowley K; Teede H; O'Neal DN
    Diabetes Care; 2010 Jun; 33(6):1242-8. PubMed ID: 20215457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and Safety of the 15-Day CareSens Air Continuous Glucose Monitoring System.
    Kim KS; Lee SH; Yoo WS; Park CY
    Diabetes Technol Ther; 2024 Apr; 26(4):222-228. PubMed ID: 38133642
    [No Abstract]   [Full Text] [Related]  

  • 16. Accuracy and Time Delay of Glucose Measurements of Continuous Glucose Monitoring and Bedside Artificial Pancreas During Hyperglycemic and Euglycemic Hyperinsulinemic Glucose Clamp Study.
    Kuroda A; Taniguchi S; Akehi Y; Mori H; Tamaki M; Suzuki R; Otsuka Y; Matsuhisa M
    J Diabetes Sci Technol; 2017 Nov; 11(6):1096-1100. PubMed ID: 28992720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.
    Pepper GM; Steinsapir J; Reynolds K
    Diabetes Technol Ther; 2012 Aug; 14(8):654-7. PubMed ID: 22690923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.
    Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
    Diabetes; 2010 Jul; 59(7):1585-90. PubMed ID: 20424232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.
    Bailey TS; Zisser HC; Garg SK
    Diabetes Technol Ther; 2007 Jun; 9(3):203-10. PubMed ID: 17561790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.